0

Global CAR T-cell Therapy Market 2018-2022

  • Published: Sep 2018
  • Pages: 109
  • SKU: IRTNTR23888
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The CAR T-cell therapy market size will grow by USD 858 million during 2018-2022. This report offers an analysis of the market based on antigen (CD19 and CD22) and geography (the Americas, APAC, and EMEA). The report analyzes the market’s competitive landscape and offers information on several companies including Bluebird Bio, CARsgen Therapeutics, Celgene, Gilead, and Novartis.

To identify growth opportunities in the CAR T-cell therapy market, the market has been segmented into regions that are growing faster than the overall market. These regions have been pitted against regions that have a slower growth rate than the global market in 2017-2022. APAC and EMEA will grow faster than the overall market. The growth of the Americas will be slower than the global market.

Below are some of the key findings from the CAR T cell therapy market research report

 

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global CAR T-cell Therapy Industry Overview

CAR T-cell therapy industry growth is expected to accelerate massively driven by increasingly proven effectiveness of CAR T-cell therapy. CAR T-cell therapy is proven to have higher efficacy than the other therapies that are currently available in the healthcare industry for the treatment of cancer. Increasing incidence of cancer and the rising number of patients showing response failure to alternative treatments is expected to foster the growth of the global CAR-T cell therapy market. Moreover, development of new and effective therapy options to cure symptoms of the disease is also a vital factor contributing to the growth of CAR T cell therapy market. Thus, increasing government initiatives for improving health care infrastructure and promoting research for cell therapy in cancer is fueling market growth. The advent of armored CAR T-cell will gain traction in the market and will help the market to register a CAGR close to 63% in the forecast period

Top CAR T-cell therapy companies covered in this market research report

The CAR T cell therapy market is moderately fragmented. Most of the established CAR T-cell therapy companies are focused on implementing CAR T-cell therapy clinical trials by out-licensing molecules or technology platforms to pharmaceutical companies. To help clients improve their market position, this report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this CAR T cell therapy market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.

The report offers a detailed analysis of several CAR T-cell therapy companies, including:

  • Bluebird bio
  • CARsgen Therapeutics
  • Celgene
  • Gilead
  • Novartis

CAR T-cell therapy market segmentation based on geographic regions

  • Americas
  • APAC
  • EMEA

With a comprehensive study of the growth opportunities for the companies, the Americas will account for the highest growth of this market throughout the forecast period.

CAR T-cell therapy market segmentation based on antigen

  • CD19
  • CD22

The CD22 segment will account for the highest growth in the market. Additionally, the report also provides an accurate prediction of the contribution of the various antigen segments to the growth of the CAR T cell therapy market size.

Key highlights of the global CAR T-cell Therapy market for the forecast years 2018-2022:

  • CAGR of the market during the forecast period 2018-2022
  • Detailed information on factors that will accelerate the growth of the CAR T cell therapy market during the next five years
  • Precise estimation of the global CAR T cell therapy market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the CAR T-cell therapy industry across the Americas, APAC, and EMEA
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on the factors that will challenge the growth of CAR T-cell therapy companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: PIPELINE

PART 08: MARKET SEGMENTATION BY ANTIGEN

  • Segmentation by antigen
  • Comparison by antigen
  • CD19 – Market size and forecast 2017-2022
  • CD22 – Market size and forecast 2017-2022
  • Others – Market size and forecast 2017-2022
  • Market opportunity by antigen

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Collaborative R&D efforts
  • Reimbursement coverage
  • Advent of armored CAR T-cells

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • bluebird bio
  • CARsgen Therapeutics
  • Celgene
  • Gilead
  • Novartis

PART 16: APPENDIX

  • List of abbreviations

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>